GPR146
G-protein coupled receptor 146
Also known as: GP146_HUMAN, PGR8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96CH1
- Gene
- GPR146
- Ensembl
- ENSG00000164849
- Chromosome
- 7
- Canonical length
- 333 aa
- Protein class
- G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables G protein-coupled receptor activity. Involved in adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway and regulation of cholesterol biosynthetic process. Is active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
333 residues, UniProt reviewed canonical sequence.
>Q96CH1|GPR146
1 MWSCSWFNGT GLVEELPACQ DLQLGLSLLS LLGLVVGVPV GLCYNALLVL ANLHSKASMT
61 MPDVYFVNMA VAGLVLSALA PVHLLGPPSS RWALWSVGGE VHVALQIPFN VSSLVAMYST
121 ALLSLDHYIE RALPRTYMAS VYNTRHVCGF VWGGALLTSF SSLLFYICSH VSTRALECAK
181 MQNAEAADAT LVFIGYVVPA LATLYALVLL SRVRREDTPL DRDTGRLEPS AHRLLVATVC
241 TQFGLWTPHY LILLGHTVII SRGKPVDAHY LGLLHFVKDF SKLLAFSSSF VTPLLYRYMN
301 QSFPSKLQRL MKKLPCGDRH CSPDHMGVQQ VLALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPR146 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 43 nTPM
- breast: 38 nTPM
- lung: 23 nTPM
- choroid plexus: 22 nTPM
- liver: 21 nTPM
- colon: 13 nTPM
Single-cell type
- extravillous trophoblasts: 390 nCPM
- syncytiotrophoblasts: 112 nCPM
- lymphatic endothelial cells: 75 nCPM
- breast lactating cells: 63 nCPM
- vascular endothelial cells: 55 nCPM
- migrating cytotrophoblasts: 51 nCPM
Immune cell
- eosinophil: 95 nTPM
- naive CD4 T-cell: 26 nTPM
- T-reg: 15 nTPM
- plasmacytoid DC: 14 nTPM
- memory CD4 T-cell: 8.4 nTPM
- naive CD8 T-cell: 4.9 nTPM
Brain region
- choroid plexus: 34 nTPM
- thalamus: 33 nTPM
- pons: 26 nTPM
- medulla oblongata: 26 nTPM
- midbrain: 26 nTPM
- cerebral cortex: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.15
- gnomAD missense Z
- -0.42
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- defense response to virus
- regulation of cholesterol biosynthetic process
- response to interferon-beta
- response to type II interferon
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPR146 as an antibody target. Whether an autoantibody or antibody against GPR146 could matter depends on whether native GPR146 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPR146 is annotated at the cell surface, where native GPR146 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPR146 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...